HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome.

AuthorsJ Junker, W Haverkamp, E Schulze-Bahr, L Eckardt, W Paulus, R Kiefer
JournalNeurology (Neurology) Vol. 59 Issue 3 Pg. 466 (Aug 13 2002) ISSN: 0028-3878 [Print] United States
PMID12177393 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Arrhythmia Agents
  • Anticonvulsants
  • Amiodarone
  • Acetazolamide
Topics
  • Acetazolamide (therapeutic use)
  • Adolescent
  • Amiodarone (therapeutic use)
  • Anti-Arrhythmia Agents (therapeutic use)
  • Anticonvulsants (therapeutic use)
  • Child
  • Drug Therapy, Combination
  • Female
  • Humans
  • Long QT Syndrome (drug therapy, genetics, physiopathology)
  • Paralyses, Familial Periodic (drug therapy, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: